dihexa pnb-0408 c-met hgfr activator Buy – CAS 1401708-83-5 Pancreatic Cancer Treatment Targeting the
Pancreatic Cancer Treatment Targeting the HGF c MET Pathway: The MEK Inhibitor Trametinib Dihexa Biorbyt Drug development of MET inhibitors: targeting oncogene addiction and expedience Nature Reviews Drug Discovery dihexa hgf c met agonist Structural basis of the activation of c MET receptor
Pay in 4 interest-free payments of $6.73 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



